SHORT T-LYMPHOCYTE TELOMERE LENGTH COMPROMISES SUSTAINED VIROLOGICAL RESPONSE WITH PEGYLATED INTERFERON-ALPHA AND RIBAVIRIN IN CHRONIC HEPATITIS C VIRUS (HCV) INFECTION

被引：0
|
作者：
Hoare, M. [1 ]
Gelson, W. T. H. [1 ]
Davies, S. E. [2 ]
Curran, M. D. [3 ]
Vowler, S. L. [4 ]
Akbar, A. N. [5 ]
Alexander, G. J. M. [1 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 2QQ, England
[3] Univ Cambridge, Clin Microbiol & Publ Hlth Lab, Hlth Protect Agcy, Cambridge CB2 2QQ, England
[4] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge CB2 2QQ, England
[5] Royal Free & Univ Coll Med Sch, Dept Immunol & Mol Pathol, London WC1E 6BT, England
来源：
GUT | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A72 / A72
页数：1
相关论文
共 50 条
  • [41] Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
    S. K. Tohra
    S. Taneja
    S. Ghosh
    B. K. Sharma
    A. Duseja
    R. K. Dhiman
    A. Das
    Y. K. Chawla
    Digestive Diseases and Sciences, 2011, 56
  • [42] PREDICTING SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN USING THE ABBOTT REALTIME HCV ASSAY AND THE ROCHE COBAS TAQMAN HCV ASSAY
    Motsuuro, Kentaro
    Tanaka, Yasuhito
    Hasegawa, Izumi
    Ohno, Tomoyoshi
    Tokuda, Hiroshi
    Sugouchi, Fuminaka
    Nojiri, Shunsuke
    Mizokami, Masashi
    HEPATOLOGY, 2008, 48 (04) : 875A - 875A
  • [43] Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection
    Tsubota, A
    Hirose, Y
    Izumi, N
    Kumada, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 360 - 367
  • [44] Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
    Tohra, S. K.
    Taneja, S.
    Ghosh, S.
    Sharma, B. K.
    Duseja, A.
    Dhiman, R. K.
    Das, A.
    Chawla, Y. K.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2449 - 2455
  • [45] Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
    Rashed, Yasser K.
    Khalaf, Fatma A.
    Kotb, Sobhy E.
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2020, 63 (02) : 52 - 55
  • [46] IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C
    Estrabaud, Emilie
    Appourchaux, Kevin
    Bieche, Ivan
    Carrat, Fabrice
    Lapalus, Martine
    Lada, Olivier
    Martinot-Peignoux, Michelle
    Boyer, Nathalie
    Marcellin, Patrick
    Vidaud, Michel
    Asselah, Tarik
    PLOS ONE, 2015, 10 (04):
  • [47] Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C
    Ogawa, Eiichi
    Furusyo, Norihiro
    Shimizu, Motohiro
    Ihara, Takeshi
    Hayashi, Takeo
    Harada, Yuji
    Toyoda, Kazuhiro
    Murata, Masayuki
    Hayashi, Jun
    ANTIVIRAL THERAPY, 2015, 20 (02) : 185 - 192
  • [48] Nitric Oxide Levels and Sustained Virological Response to Pegylated-Interferon alpha2a plus Ribavirin in Chronic HCV Genotype 4 Hepatitis: a Prospective Study
    Ibrahim, Mohamed
    Gomaa, Wafaey
    Ibrahim, Yehia
    El Hadad, Hazem
    Shatat, Mohamed
    Aleem, Ashraf Abdel
    Essawy, Mohamed
    Fouad, Yasser M.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2010, 19 (04) : 387 - 392
  • [49] Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis
    Sabbatani, S
    Manfredi, R
    Marinacci, G
    Pavoni, M
    Cristoni, L
    Chiodo, F
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (03) : 205 - 208
  • [50] Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin
    Striki, A.
    Manolakopoulos, S.
    Deutsch, M.
    Mela, M.
    Kalafateli, M.
    Schini, M.
    Anagnostou, O.
    Triantos, C.
    Andreadis, I.
    Ketikoglou, I.
    Papatheodoridis, G.
    Pectasides, D.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (09) : 624 - 632
12345